Labelling information improved
The content regarding the labelling of investigational medicinal products on the CCMO website has been updated.
The update now states more clearly which information should be included in CTIS, and how to deal with symbols, contact details, and language. Separate sections have been added for unauthorized and authorized medicinal products, radiopharmaceuticals, and pharmaceutical preparations.
This text now better aligns with CTR regulations and associated guidelines.